George Eby joins Adeona's SAB
This article was originally published in Scrip
Executive Summary
Adeona Pharmaceuticals has appointed George Eby to its scientific advisory board. Though the company focuses on developing treatments for CNS disorders, Mr Eby will provide expertise for its common cold programme, as he has conducted multiple clinical studies of zinc lozenges for the common cold over 30 years as a researcher, and is the executive director of the George Eby Research Institute.